Загрузка...
Co-mutations of TP53 and KRAS serve as potential biomarkers for immune checkpoint blockade in squamous-cell non-small cell lung cancer: a case report
BACKGROUND: Unprecedented durable responses are identified in clinical studies to target the signaling of programmed cell death protein-1 (PD-1) as well as its ligand (PD-L1) in patients with squamous-cell non-small cell lung cancer (NSCLC). However, factors predicting the patient subtypes that are...
Сохранить в:
| Опубликовано в: : | BMC Med Genomics |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6794845/ https://ncbi.nlm.nih.gov/pubmed/31619231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12920-019-0592-6 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|